The euro reached its highest level since early March after the European Union agreed on a deal for a massive stimulus package to support the bloc’s economy from the coronavirus pandemic.
The deal was finalized after a round of compromises between the thrifty northerners and the more extravagant countries in the EU.
The deal lifted the euro by 0.2% to $1.1470, its highest since March 9.
Adding to the broader appetite for the euro and other commodity currencies were the positive results from two COVID-19 early vaccine trials.
The dollar index sat at 95.813, while the commodity currency Australian dollar rose 0.5% to $0.7049, its strongest since early June.
The pound was also lifted by the risk sentiment, growing 0.4% to 1.2716 on the dollar. It gained 0.3% to 90.16 pence per euro.
Markets were generally steady, with most currencies trading in ranges.
The Japanese yen was flat at 107.31 per dollar.
European shares traded lower earlier on Thursday after underwhelming earnings reports dampened a U.S. Fed vow to continue rolling out stimulus plans in a bid to soften the economic blow of the COVID-19 pandemic. The pan-European STOXX lost ...
The dollar was briefly lifted on Thursday after the U.S. Federal Reserve offered no concrete clues about its next course of action, while investors hoped for an easy policy as the coronavirus resurgence stalled economic recovery. The dollar ...
On Tuesday, Tesla Inc.’s (TSLA.O) Chief Executive Officer Elon Musk announced that the automotive company would start to open its licensing software to supply powertrains and batteries for other car manufacturers. “Tesla is open ...
Oil prices climbed on Wednesday after U.S. crude inventories fell against analysts’ expectations, prompting a boost in the market amid the coronavirus resurgence. Brent crude futures gained 0.3%, or 14 cents, at $43.36 per barrel. U.S. ...
Britain on Wednesday signed a supply deal for up to 60 million doses of a possible COVID-19 vaccine that is being developed by pharmaceutical companies GlaxoSmithKline (GSK) and Sanofi. The financial details of the agreement were not disclosed. However, ...